airis PHARMA’s vision is to develop generic formulation products for the US market and other markets such as Europe, NZ-Aus, Turkey, and UK. The generic products range in complexity from oral solids to injectables. The company is located in Hyderabad, India.
The teams and the facility are geared toward development of diverse dosage forms with a mission of adding value. Facility is 100% Exported Oriented Unit. Teams are equipped with necessary instrumentation and equipment to formulate and test products. The team members have B Pharm / M Pharm degrees with industrial experience in formulation development, analytical method development, and technology transfer along with their depth in quality assurance and regulatory affairs, provide a solid platform to develop products built on fundamentals and high quality for the regulated markets to meet the current regulatory guidelines.
Teams work in an atmosphere that is completely empowered and have the full sense of ownership needed to bring the quality products to fruition. The company’s mantra is ‘simply quality focused’ and the teams believe it will be the key to success. Using a well conceived quality management system and implementing Quality by Design (QbD), the teams ensure that quality will be built into drug products during development and will continue during commercial manufacturing. This mindset will ensure that drug products meet therapeutic and pharmaceutical equivalence leading to patient compliance.